Skip to main content
. 2021 May 1;10(10):3214–3223. doi: 10.1002/cam4.3881

FIGURE 2.

FIGURE 2

PFS (a) and OS (b) for all infused patients and for patients achieving CR at first disease assessment. Note: PFS and OS in infused patients and in patients achieving CR after CAR T‐cell infusion